Literature DB >> 1601129

Phosphorylation sequences in h-caldesmon from phorbol ester-stimulated canine aortas.

L P Adam1, C J Gapinski, D R Hathaway.   

Abstract

The high molecular weight form of caldesmon (h-caldesmon) is phosphorylated in vascular smooth muscle. The stoichiometry of caldesmon phosphorylation increases in response to stimulation of the muscle by several contractile agonists; however, the responsible kinase has not been identified. In this study, we have sequenced the phosphopeptides prepared from h-caldesmon phosphorylated in vitro by protein kinase C (PKC) as well as the phosphopeptides prepared from caldesmon phosphorylated in intact canine aortas that were stimulated to contract with PDBu. PKC phosphorylated three sites located in the C terminus: GSS*LKIEE, AEFLNKS*VQK and NLWEKQS*VDK, while h-caldesmon from intact tissue was phosphorylated at two separate sites also in the C terminus: VTS*PTKV and S*PAPK. By comparison to known substrate consensus sequences for various protein kinases these data suggest that h-caldesmon is directly phosphorylated by a proline-directed protein kinase and not by PKC.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1601129     DOI: 10.1016/0014-5793(92)80446-n

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

1.  Cytoskeletal targeting of calponin in differentiated, contractile smooth muscle cells of the ferret.

Authors:  C A Parker; K Takahashi; J X Tang; T Tao; K G Morgan
Journal:  J Physiol       Date:  1998-04-01       Impact factor: 5.182

2.  Contractile effects of vanadate on aorta rings from virgin and pregnant rats.

Authors:  J St-Louis; B Sicotte; E Breton; A K Srivastava
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

3.  Phosphorylation of caldesmon by smooth-muscle casein kinase II.

Authors:  C Sutherland; B S Renaux; D J McKay; M P Walsh
Journal:  J Muscle Res Cell Motil       Date:  1994-08       Impact factor: 2.698

4.  Sensitization of the contractile system of canine colonic smooth muscle by agonists and phorbol ester.

Authors:  K Sato; R Leposavic; N G Publicover; K M Sanders; W T Gerthoffer
Journal:  J Physiol       Date:  1994-12-15       Impact factor: 5.182

Review 5.  Caldesmon as a therapeutic target for proliferative vascular diseases.

Authors:  Chi-Ming Hai
Journal:  Mini Rev Med Chem       Date:  2008-10       Impact factor: 3.862

6.  Caldesmon regulates the motility of vascular smooth muscle cells by modulating the actin cytoskeleton stability.

Authors:  Qifeng Jiang; Renjian Huang; Shaoxi Cai; Chih-Lueh A Wang
Journal:  J Biomed Sci       Date:  2010-02-03       Impact factor: 8.410

Review 7.  Smooth muscle signalling pathways in health and disease.

Authors:  H R Kim; S Appel; S Vetterkind; S S Gangopadhyay; K G Morgan
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

8.  Disulphide cross-linking of smooth-muscle and non-muscle caldesmon to the C-terminus of actin in reconstituted and native thin filaments.

Authors:  P Graceffa; L P Adam; W Lehman
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

9.  Smooth-muscle caldesmon phosphatase is SMP-I, a type 2A protein phosphatase.

Authors:  M D Pato; C Sutherland; S J Winder; M P Walsh
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

10.  Modulation of actin mechanics by caldesmon and tropomyosin.

Authors:  M J Greenberg; C-L A Wang; W Lehman; J R Moore
Journal:  Cell Motil Cytoskeleton       Date:  2008-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.